<DOC>
	<DOC>NCT02204163</DOC>
	<brief_summary>Evaluate the efficacy and safety after treatment of Eutropin® inj. compared to Genotropin® in infants/toddlers with Prader-Willi syndrome</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prader-Willi Syndrome</mesh_term>
	<criteria>Genetically diagnosed PraderWilli Syndrome Prepubertal at start of treatment; assessed by Tanner stage 1 Known presence or history of malignancy Impaired Fasting Glucose or Diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>